|
1
|
Michalek IM, Loring B and John SM: A
systematic review of worldwide epidemiology of psoriasis. J Eur
Acad Dermatol Venereol. 31:205–212. 2017. View Article : Google Scholar
|
|
2
|
Zhao Na: Epidemiologycal analysis on
psoriasis vulgaris in a hospital for skin diseases (unpublished PhD
thesis). Shandong University; 2011
|
|
3
|
Napolitano M, Megna M and Monfrecola G:
Insulin resistance and skin diseases. ScientificWorldJournal.
2015:4793542015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gu Y and Nordstrom BL: The risk of
malignancy among biologic-naive pediatric psoriasis patients: A
retrospective cohort study in a US claims database. J Am Acad
Dermatol. 77:293–301.e1. 2017. View Article : Google Scholar
|
|
5
|
Di Meglio P, Villanova F and Nestle FO:
Psoriasis. Cold Spring Harb Perspect Med. 4:a0153542014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McCormick R, McDonagh B and
Goljanek-Whysall K: microRNA-SIRT-1 interactions: Key regulators of
adult skeletal muscle homeostasis? J Physiol. 595:3253–3254. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
George J and Ahmad N: Mitochondrial
sirtuins in cancer: Emerging roles and therapeutic potential.
Cancer Res. 76:2500–2506. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Busch F, Mobasheri A, Shayan P, Stahlmann
R and Shakibaei M: Sirt-1 is required for the inhibition of
apoptosis and inflammatory responses in human tenocytes. J Biol
Chem. 287:25770–25781. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding RB, Bao J and Deng CX: Emerging roles
of SIRT1 in fatty liver diseases. Int J Biol Sci. 13:852–867. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moynihan KA, Grimm AA, Plueger MM,
Bernal-Mizrachi E, Ford E, Cras-Méneur C, Permutt MA and Imai S:
Increased dosage of mammalian Sir2 in pancreatic beta cells
enhances glucose-stimulated insulin secretion in mice. Cell Metab.
2:105–117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gertler AA and Cohen HY: SIRT6, a protein
with many faces. Biogerontology. 14:629–639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Buechler N, Wang X, Yoza BK, McCall CE and
Vachharajani V: Sirtuin 2 regulates microvascular inflammation
during sepsis. J Immunol Res. 2017:26489462017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sack MN and Finkel T: Mitochondrial
metabolism, sirtuins, and aging. Cold Spring Harb Perspect Biol.
4:a0131022012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mathias RA, Greco TM and Cristea IM:
Identification of Sirtuin4 (SIRT4) protein interactions: Uncovering
candidate acyl- modified mitochondrial substrates and enzymatic
regulators. Methods Mol Biol. 1436:213–239. 2016. View Article : Google Scholar
|
|
15
|
Kiran S, Anwar T, Kiran M and Ramakrishna
G: Sirtuin 7 in cell proliferation, stress and disease: Rise of the
seventh sirtuin! Cell Signal. 27:673–682. 2015. View Article : Google Scholar
|
|
16
|
Rasheed H, El-Komy M, Hegazy RA, Gawdat
HI, AlOrbani AM and Shaker OG: Expression of sirtuins 1, 6, tumor
necrosis factor, and interferon-gamma in psoriatic patients. Int J
Immunopathol Pharmacol. 29:764–768. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie S, Su Z, Zhang B, Ge J, Song S, Sun G,
Sun X, Yi L, Wang Y, Sun W, et al: SIRT1 activation ameliorates
aldara-induced psoriasiform phenotype and histology in mice. J
Invest Dermatol. 135:1915–1918. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun J, Han J, Zhu Q, Li Z and Hu J:
Camptothecin fails to induce apoptosis in tumor necrosis
factor-alpha-treated HaCaT cells. Pharmacology. 89:58–63. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cho JW, Lee KS and Kim CW: Curcumin
attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well
as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs
as potential upstream targets. Int J Mol Med. 19:469–474.
2007.PubMed/NCBI
|
|
20
|
Xiong H, Xu Y, Tan G, Han Y, Tang Z, Xu W,
Zeng F and Guo Q: Glycyrrhizin ameliorates imiquimod-induced
psoriasis-like skin lesions in BALB/c mice and inhibits
TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells. Cell
Physiol Biochem. 35:1335–1346. 2015. View Article : Google Scholar
|
|
21
|
Li R, Wang J, Wang X, Zhou J, Wang M, Ma H
and Xiao S: Increased βTrCP are associated with imiquimod-induced
psoriasis- like skin inflammation in mice via NF-κB signaling
pathway. Gene. 592:164–171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Cai Y, Fleming C and Yan J: New insights
of T cells in the pathogenesis of psoriasis. Cell Mol Immunol.
9:302–309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jeon YJ, Sah SK, Yang HS, Lee JH, Shin J
and Kim TY: Rhododendrin inhibits toll-like receptor-7-mediated
psoriasis- like skin inflammation in mice. Exp Mol Med.
49:e3492017. View Article : Google Scholar
|
|
25
|
Schwarz G, Boehncke WH, Braun M, Schröter
CJ, Burster T, Flad T, Dressel D, Weber E, Schmid H and Kalbacher
H: Cathepsin S activity is detectable in human keratinocytes and is
selectively upregulated upon stimulation with interferon-gamma. J
Invest Dermatol. 119:44–49. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vachharajani VT, Liu T, Wang X, Hoth JJ,
Yoza BK and McCall CE: Sirtuins link inflammation and metabolism. J
Immunol Res. 2016:81672732016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sestito R, Madonna S, Scarponi C,
Cianfarani F, Failla CM, Cavani A, Girolomoni G and Albanesi C:
STAT3-dependent effects of IL-22 in human keratinocytes are
counterregulated by sirtuin 1 through a direct inhibition of STAT3
acetylation. FASEB J. 25:916–927. 2011. View Article : Google Scholar
|
|
28
|
Torii S, Yamamoto T, Tsuchiya Y and
Nishida E: ERK MAP kinase in G cell cycle progression and cancer.
Cancer Sci. 97:697–702. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kwon TR, Oh CT, Choi EJ, Kim SR, Jang YJ,
Ko EJ, Suh D, Yoo KH and Kim BJ: Ultraviolet light-emitting-diode
irradiation inhibits TNF-α and IFN-gamma-induced expression of
ICAM-1 and STAT1 phosphorylation in human keratinocytes. Lasers
Surg Med. 47:824–832. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma S, Rao L, Freedberg IM and Blumenberg
M: Transcriptional control of K5, K6, K14, and K17 keratin genes by
AP-1 and NF-kappaB family members. Gene Expr. 6:361–370.
1997.PubMed/NCBI
|
|
31
|
Harijith A, Ebenezer DL and Natarajan V:
Reactive oxygen species at the crossroads of inflammasome and
inflammation. Front Physiol. 5:3522014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu TF, Vachharajani VT, Yoza BK and
McCall CE: NAD+-dependent sirtuin 1 and 6 proteins
coordinate a switch from glucose to fatty acid oxidation during the
acute inflammatory response. J Biol Chem. 287:25758–25769. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
D'Onofrio N, Servillo L and Balestrieri
ML: SIRT1 and SIRT6 signaling pathways in cardiovascular disease
protection. Antioxid Redox Signal. 28:711–732. 2018. View Article : Google Scholar :
|
|
34
|
Serravallo M, Jagdeo J, Glick SA, Siegel
DM and Brody NI: Sirtuins in dermatology: Applications for future
research and therapeutics. Arch Dermatol Res. 305:269–282. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiao C, Wang RH, Lahusen TJ, Park O,
Bertola A, Maruyama T, Reynolds D, Chen Q, Xu X, Young HA, et al:
Progression of chronic liver inflammation and fibrosis driven by
activation of c-JUN signaling in Sirt6 mutant mice. J Biol Chem.
287:41903–41913. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hirschey MD, Shimazu T, Jing E, Grueter
CA, Collins AM, Aouizerat B, Stančáková A, Goetzman E, Lam MM,
Schwer B, et al: SIRT3 deficiency and mitochondrial protein
hyperacety-lation accelerate the development of the metabolic
syndrome. Mol Cell. 44:177–190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kiran Z, Zuberi BF, Anis D, Qadeer R,
Hassan K and Afsar S: Insulin resistance in non-diabetic patients
of chronic Hepatitis C. Pak J Med Sci. 29:201–204. 2013.PubMed/NCBI
|
|
38
|
Milčić D, Janković S, Vesić S, Milinković
M, Marinković J, Ćirković A and Janković J: Prevalence of metabolic
syndrome in patients with psoriasis: A hospital-based
cross-sectional study. An Bras Dermatol. 92:46–51. 2017. View Article : Google Scholar
|
|
39
|
Liakou AI and Zouboulis CC: Links and
risks associated with psoriasis and metabolic syndrome. Psoriasis
(Auckl). 5:125–128. 2015.
|
|
40
|
Owczarczyk-Saczonek AB and Nowicki RJ:
Prevalence of cardiovascular disease risk factors, and metabolic
syndrome and its components in patients with psoriasis aged 30 to
49 years. Postepy Dermatol Alergol. 32:290–295. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Blank MF and Grummt I: The seven faces of
SIRT7. Transcription. 8:67–74. 2017. View Article : Google Scholar : PubMed/NCBI
|
